Loading clinical trials...
Loading clinical trials...
A Randomized Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
Conditions
Interventions
Mifepristone, misoprostol
Locations
9
Moldova
State University of Medicine and Pharmacy
Chisinau, Moldova
Centre de Planification Familiale de l'Ariana
Aryanah, Tunisia
Centre de Planification Familiale la Bardo
Tunis, Tunisia
Maternité de La Rabta
Tunis, Tunisia
Private clinic
Tunis, Tunisia
Dr. Zekai Tahir Burak Women's Health Training and Research Hospital
Ankara, Turkey (Türkiye)
Start Date
August 1, 2005
Primary Completion Date
January 1, 2008
Completion Date
January 1, 2008
Last Updated
February 19, 2014
Lead Sponsor
Gynuity Health Projects
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions